29,056 resources
By Version
By Authority
By Realm
Start Prev Rows 22200 - 22400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
Test.Training | R3 | CareConnect-OutcomeOfAttendance-1 | NHS Data Model and Dictionary Outcome Of Attendance | draft | 2018-11 | hl7 | ||||
us.cdc.phinvads | R4 | 2.16.840.1.113883.1.11.19185 | Religious Affiliation Value Set | active | 2009-01 | us | tho | |||
hl7.terminology | R5 | v3-RoleLinkReplaces | RoleLinkReplaces | active | 2014-03 | uv | hl7 | tho | ||
hl7.terminology | R5 | v3-RoleLinkIsBackupFor | RoleLinkIsBackupFor | active | 2014-03 | uv | hl7 | tho | ||
ca.on.oh-olis | R4 | olis-ObservationCodesProvider | ObservationCodes | active | hl7 | |||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1147.120 | Major Injuries | active | 2024-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.205 | Moderate Injuries | active | 2024-10 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1272.2 | Moderate Injuries (SNOMEDCT) | active | 2025-02 | us | hl7 | sct | ||
hl7.fhir.us.davinci-pas | R4 | X12278ConditionCode | X12 278 CRC Condition Code | trial-use | 3 | fm | 2025-07 | us | hl7 | x12 |
hl7.fhir.us.davinci-pas | R4 | X12278NutritionEnteralFormulaType | X12 278 Nutrition Enteral Formula Type | trial-use | 3 | fm | 2025-07 | us | hl7 | cms |
hl7.fhir.us.davinci-pas | R4 | X12278RequestedServiceModifierType | X12 278 Requested Service Modifier Type | trial-use | 3 | fm | 2025-07 | us | hl7 | cpt cms |
hl7.fhir.us.davinci-pas | R4 | X12278NutritionOralDietType | X12 278 Nutrition Oral Diet Type | trial-use | 3 | fm | 2025-07 | us | hl7 | cms |
hl7.fhir.us.davinci-pas | R4 | X12278ConditionCategory | X12 278 CRC Condition Category | trial-use | 3 | fm | 2025-07 | us | hl7 | x12 |
hl7.fhir.us.davinci-pas | R4 | X12278RequestedServiceType | X12 278 Requested Service Type | trial-use | 3 | fm | 2025-07 | us | hl7 | cpt x12 cms tho ndc |
hl7.fhir.us.davinci-pas | R4 | X12278LocationType | X12 278 Health Care Service Location Type Value Set | trial-use | 3 | fm | 2025-07 | us | hl7 | cms |
hl7.fhir.us.davinci-pas | R4 | X12278DiagnosisType | X12 278 Diagnosis Type Value Set | trial-use | 3 | fm | 2025-07 | us | hl7 | fhir |
il.core.fhir.r4 | R4 | il-core-parent-name-role | The role of the parent (father/mother) whose name is recorded | active | il | national | tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.113762.1.4.1018.98 | Route of Administration | active | 2016-01 | us | sct | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.3 | Pulmonary Embolism Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.2 | Fracture Exclusions For Hip And Knee Procedures | active | 2019-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.1 | Mechanical Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.8 | Periprosthetic Joint Infection/Wound Infection and Other Wound Complications | active | 2019-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.10 | Surgical Site Bleeding and Other Surgical Site Complications | active | 2019-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.9 | Procedures Resulted From Periprosthetic Joint Infection/Wound Infections | active | 2019-06 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.11 | Procedures Resulted From Surgical Site Bleeding and Other Surgical Site Complications | active | 2019-06 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.7 | Malignant Neoplasm Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.6 | Pneumonia Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.206 | Infecund Not for Contraceptive Reasons ICD10PCS Procedures | active | 2022-06 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.4 | Sepsis Complications Related To Hip and Knee Procedures | active | 2019-06 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.53 | Reasons for Interventions Related to Medication Management, Adverse Events | active | 2024-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1206.5 | Nonprimary Total Hip, Total Knee Replacement | active | 2019-06 | us | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.24 | Malnutrition Assessment | active | 2015-11 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.29 | Malnutrition Assessment | active | 2022-03 | us | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.33 | Nutrition Assessment Procedure | active | 2015-11 | us | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.113883.1.11.18877 | Coverage Role Type Value Set | active | 2009-01 | us | tho | |||
ca.on.ehr.r4 | R4 | ValueSet-DIN | DIN All Code | active | 1899-12 | ca | national | fhir | ||
ca.infoway.io.psca | R4 | din | DIN All Concepts | draft | 2025-03 | ca | national | fhir | ||
ca.infoway.io.psca | R4 | CCI | Canadian Classification of Health Interventions All Concepts | active | 2022-01 | ca | national | |||
ca.infoway.io.core | R4 | codecci | Canadian Classification of Health Interventions All Concepts | draft | 2025-03 | ca | national | |||
ca.infoway.io.psca | R4 | HealthCanadaNaturalProductNumber | Health Canada Natural Product Number (hcNPN) | active | 2022-01 | ca | national | tho | ||
ca.on.ehr.r4 | R4 | ValueSet-ICD10CAAllCode | International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada All Concepts | active | 2022-01 | ca | national | fhir | ||
accdr.fhir.ig.pkg | R4 | ICD10CA | International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada All Concepts | active | 2022-01 | ca | national | fhir | ||
ca.infoway.io.psca | R4 | ICD9CM | ICD-9 CM All Concepts | active | 2022-01 | ca | national | tho | ||
ca.on.ehr.r4 | R4 | ValueSet-ICD9CMAllCode | ICD-9 CM All Concepts | active | 2022-01 | ca | national | icd | ||
ca.on.ehr.r4 | R4 | ValueSet-LicensedNaturalHealthProducts | Licensed Natural Health Products | active | 2025-04 | ca | national | tho | ||
ca.on.dhdr.r4.v4 | R4 | licensed-natural-health-products | Licensed Natural Health Products | active | 2022-03 | us | hl7 | tho | ||
ca.on.ehr.r4 | R4 | ValueSet-MedicationReasonCode | Medication Reason Code | active | 1899-12 | ca | national | sct | ||
ca.on.oh.erec | R4 | SeverityCode | SeverityCode | draft | 2022-08 | ca | national | |||
ca.infoway.io.core | R4 | SS-ProcedureCode-1-0-0 | ProcedureCode | draft | 2024-05 | ca | national | sct | ||
ca.infoway.io.psca | R4 | allergicconditioncode | Allergic Condition Code | draft | ca | national | sct | |||
ca.infoway.io.core | R4 | anatomicaloracquiredbodystructurecode | Anatomical Or Acquired Body Structure Code | draft | 2025-03 | ca | national | sct | ||
ca.on.ehr.r4 | R4 | ValueSet-ClinicalFindingCode | ClinicalFindingCode | active | 1899-12 | ca | national | sct | ||
ca.infoway.io.core | R4 | pharmaceuticalbiologicproductcode | Pharmaceutical/Biologic Product Code | draft | 2022-02 | ca | national | sct | ||
ca.infoway.io.core | R4 | substancecode | Substance Code | draft | 2025-03 | ca | national | sct | ||
ca.infoway.io.core | R4 | SS-HealthConditionCode-1-0-0 | HealthConditionCode | draft | 2025-02 | ca | national | sct | ||
ca.on.ehr.r4 | R4 | routeofadministration | Route Of Administration | active | 1899-12 | ca | national | sct | ||
ca.infoway.io.core | R4 | socialhistorycode | Social History | draft | 2025-03 | ca | national | sct | ||
ca.infoway.io.psca | R4 | drugormedicamentsubstancecode | Drug Or Medicament Substance Code | draft | 1899-12 | ca | national | sct | ||
ca.on.ehr.r4 | R4 | ValueSet-PharmaceuticalBiologicProductAndSubstanceCode | PharmaceuticalBiologicProductAndSubstanceCode | active | 1899-12 | ca | national | sct | ||
hl7.terminology | R5 | v3-RoleClass | RoleClass | active | 2014-03 | uv | hl7 | tho | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6040 | VIS Vaccines (IIS) | active | 2021-01 | us | cvx | |||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.19 | ProblemAct statusCode | active | 2024-06 | us | hl7 | tho | ||
hl7.fhir.us.dme-orders | R4 | PAOX-Task-Code | PAO Task Code Value Set | draft | 2023-06 | us | hl7 | fhir | ||
hl7.fhir.us.cqfmeasures | R4 | subject-type | Subject Type Value Set | active | cqi | 2024-08 | us | hl7 | fhir | |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.178 | Misoprostol | active | 2024-04 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.18 | Treatment Intervention Preferences at End of Life Ordinal LOINC | active | 2023-02 | us | hl7 | loinc | ||
ihe.pcc.mpsc | R4 | Weight.Estimation.Tape.Values.VS | Physical Finding of Pelvis and Genitourinary Value Set | draft | 2025-03 | uv | ihe | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.204 | Pregnancy Labs, Blood/Serum/Plasma/Urine | active | 2024-04 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.183 | Clomiphene (Selective Estrogen Receptor Modulator / SERM) | active | 2024-04 | us | hl7 | rx | ||
hl7.fhir.us.core | R4 | us-core-screening-assessment-condition-category | US Core Screening Assessment Condition Category | trial-use | 3 | cgp | 2024-11 | us | hl7 | fhir |
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1267.31 | Healthcare Service Location Type Combined | active | 2025-05 | us | hl7 | vsac | ||
hl7.terminology | R5 | yes-no-unknown-not-asked | Yes No Unknown NotAsked | active | 2020-06 | uv | hl7 | tho | ||
de.gecco | R4 | gecco-valueset-vaccines-atc | Vaccines ATC | active | ||||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.460 | Cluster Headache (ICD10CM) | active | 2025-05 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.461 | Cluster Headache (ICD9CM) | active | 2025-05 | us | hl7 | icd | ||
ca.on.oh-olis | R4 | olis-MicroorganismCodes | MicroorganismCodes | active | hl7 | sct | ||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.467 | Medication Therapy for Cluster Headache (RXNORM) | active | 2025-05 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.91 | Rho(D) Immune Globulin | active | 2023-07 | us | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.192 | Immunosuppressive Medication RxNorm | active | 2022-03 | us | hl7 | rx | ||
de.gecco | R4 | gecco-valueset-vaccines-snomed | Vaccines SNOMED | active | sct | |||||
ndhm.in.mirror | R4 | ndhm-diagnosis-use | Diagnosis Use | draft | 2020-08 | in | national | sct | ||
ndhm.in.mirror | R4 | ndhm-route-of-administration | Route Of Administration | draft | 2020-08 | in | national | sct | ||
ndhm.in.mirror | R4 | ndhm-specimen-types | Specimen Types | draft | 2020-08 | in | national | sct | ||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-benefit-restriction | RTPBC Benefit Restriction Value Set | trial-use | 4 | phx | 2020-05 | us | hl7 | fhir |
hl7.fhir.us.specialty-rx | R4 | specialty-rx-consent-status | Specialty Rx Value Set - Consent Status | active | 2020-12 | us | hl7 | fhir | ||
ca.on.ehr.r4 | R4 | ValueSet-ProvincialImagingReportCode | Provincial Imaging Report Code EHR | active | 2025-08 | ca | national | |||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-country-code | RTPBC Country Code Value Set | trial-use | 4 | phx | 2020-05 | us | hl7 | iso |
accdr.fhir.ig.pkg | R4 | local-document-types | Local Document Types | active | 2018-12 | oid | ||||
ca.on.mi.pkg | R4 | local-document-types | Local Document Types | active | 2018-12 | ca | oid | |||
ca.on.ehr.r4 | R4 | local-PV1-4values | Local Encounter Type | active | 2018-12 | ca | national | oid | ||
npu-terminology | R4 | NPUFull | Full NPU Terminology Value Set | active | 2025-06 | uv | ||||
ca.on.mi.pkg | R4 | mi-procedure-type-provincial | Medical Imaging Provincial Procedure Type | active | 2024-04 | ca | ||||
ca.on.oh-olis | R4 | DiagnosisCodes | DiagnosisCodes | draft | hl7 | fhir | ||||
hl7.fhir.us.sdoh-clinicalcare | R4 | SDOHCC-ValueSetLOINCSNOMEDCT | SDOHCC ValueSet LOINC SNOMEDCT | trial-use | 2 | pc | 2025-05 | us | hl7 | sct loinc |
hl7.fhir.eu.hdr | R4 | sdoh-obs-snomed-loinc-eu-hdr | SDOH Observation codes | draft | 2025-06 | eu | hl7 | sct loinc | ||
hl7.fhir.uv.pharm-quality | R5 | vs-country-pq | ISO Country two letter codes | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-batch-designation-pq | Batch Designation | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-closureTypes-pq | Closure Types | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-containerOrientation-pq | Container Orientations | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-deviceProperty-pq | Device Properties | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-diagramType-pq | Diagram Types | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-color-pq | Colors | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-impurity-origin-pq | Impurity Origins | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-impurity-type-pq | Impurity Types | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-ingredientFunction-pq | Ingredient Function | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-equipmentClass-pq | Equipment Classes | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-manufacturingParticipantRole-pq | Manufacturing Participant Role | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-manufacturingStepScale-pq | Manufacturing Step Scale | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-manufacturingStep-pq | Manufacturing Step | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-grade-pq | Grades | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-packageProperty-pq | Package Property | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-pharmaceutical-organization-type | Pharmaceutical Organization Type | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-planType-pq | Plan Type | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-reportType-pq | Report Type | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-processParameter-pq | Process Parameter | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-productSiteUtilizationType-pq | Product Site Utilization | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-characterizationStep-pq | Characterization Steps | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-testCategory-pq | Test Category | active | brr | 2024-05 | uv | hl7 | tho | |
eu.miabis.r4 | R4 | miabis-detailed-sample-type-vs | DetailedSampleTypeVS | active | ||||||
hl7.fhir.us.pdmp | R4 | pdmp-rx-transmission-method | PDMP Value Set - Prescription Transmission Method | active | phx | 2024-04 | us | hl7 | tho | |
hl7.fhir.uv.pharm-quality | R5 | vs-timePointDescription-pq | Time Point Description | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.us.pdmp | R4 | pdmp-species-type | PDMP Value Set - Species Type | active | phx | 2024-04 | us | hl7 | tho | |
hl7.fhir.us.pdmp | R4 | pdmp-response-status | PDMP Value Set - Response Status | active | phx | 2024-04 | us | hl7 | fhir tho | |
hl7.fhir.us.ecr | R4 | us-ph-pregnancy-status | US Public Health Pregnancy Status | active | pher | 2018-07 | us | hl7 | vsac tho | |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-pregnancy-status | US Public Health VaueSet - Pregnancy Status | active | 2018-07 | us | hl7 | vsac tho | ||
hl7.fhir.us.ecr | R4 | us-ph-valueset-priority | US Public Health ValueSet Priority | active | pher | 2018-07 | us | hl7 | fhir | |
hl7.fhir.us.ph-library | R4 | us-ph-valueset-priority | US Public Health ValueSet Priority | active | 2021-07 | us | hl7 | fhir | ||
hl7.fhir.us.pdmp | R4 | pmix-method-of-payment | PDMP Value Set - Method of Payment | active | phx | 2024-04 | us | hl7 | tho | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.89 | D(Rh) Type | active | 2024-06 | us | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.113883.10.20.15.2.5.7 | eICR Processing Status Reason (eCR) | active | 2017-01 | us | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.113883.10.20.15.2.5.5 | Reportability Priority (eCR) | active | 2017-01 | us | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.113883.10.20.15.2.5.8 | eICR Processing Status (eCR) | active | 2017-01 | us | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.113883.10.20.15.2.5.10 | eICR Processing Status Reason Detail Type (eCR) | active | 2017-01 | us | oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.113883.10.20.15.2.5.4 | External Resource Type (eCR) | active | 2017-01 | us | oid | |||
hl7.fhir.us.ecr | R4 | valueset-ecr-messageheader-event | eCR MessageHeader Event Value Set | active | pher | 2025-03 | us | hl7 | fhir | |
hl7.fhir.us.vr-common-library | R4 | ValueSet-coded-race-and-ethnicity-person-vr | Coded Race and Ethnicity Person Vital Records | active | pher | 2025-05 | us | hl7 | fhir | |
hl7.fhir.us.vr-common-library | R4 | ValueSet-role-vr | Value Set - Role Vital Records | active | pher | 2025-05 | us | hl7 | tho | |
us.cdc.phinvads | R4 | 2.16.840.1.113883.10.20.15.2.5.3 | Determination of Reportability (eCR) | active | 2017-01 | us | oid | |||
hl7.fhir.us.pdmp | R4 | pdmp-opioid-treatment-code | PDMP Value Set - Opioid Treatment Code | active | phx | 2024-04 | us | hl7 | tho | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.81 | Estimated Date of Delivery Including Method | active | 2024-06 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.82 | Estimated Gestational Age Code Including Method | active | 2024-06 | us | hl7 | loinc | ||
ihe.qrph.bfdr | R4 | cigarette-smoking-before-during-pregnancy | Cigarette Smoking Before and During Pregnancy | active | 2024-07 | uv | ihe | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.88 | Pregnancy Related Findings | active | 2024-06 | us | hl7 | sct | ||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-patient-pay-type | RTPBC Patient Pay Type Value Set | trial-use | 4 | phx | 2020-05 | us | hl7 | fhir |
snomed-ig | R4 | bmi | BMI Observable entity Code | active | 2025-07 | sct | ||||
snomed-ig | R4 | allergyintolerance-finding-code | Allergy-Intolerance Finding Code | active | 2025-07 | sct | ||||
snomed-ig | R4 | bodyheight | Body Height Observable entity Codes | active | 2025-07 | sct | ||||
snomed-ig | R4 | bodyweight | Body weight Observable entity Code | active | 2025-07 | sct | ||||
hsos.eWundbericht | R4 | procedure-category | Maßnahme - Kategorie | draft | 2019-11 | sct | ||||
snomed-ig | R4 | bodytemp | Core body temperature Observable entity Code | active | 2025-07 | sct | ||||
snomed-ig | R4 | dia-bp | Diastolic blood pressure Observable entity Code | active | 2025-07 | sct | ||||
snomed-ig | R4 | headcircum | Head circumference Observable entity Code | active | 2025-07 | sct | ||||
snomed-ig | R4 | heartrate | Heart rate Observable entity Code | active | 2025-07 | sct | ||||
snomed-ig | R4 | oxygensat | Peripehral oxygen saturation Observable entity Code | active | 2025-07 | sct | ||||
snomed-ig | R4 | resprate | Respiratory rate Observable entity Code | active | 2025-07 | sct | ||||
hsos.eWundbericht | R4 | allergie-code | Edukation Code | draft | 2019-11 | sct | ||||
hsos.eWundbericht | R4 | allergie-code | Allergie Code | draft | 2019-11 | sct | ||||
snomed-ig | R4 | syst-bp | Systolic blood pressure Observable entity Code | active | 2025-07 | sct | ||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1034.464 | Cluster Headache | active | 2023-12 | us | hl7 | vsac | ||
ca.on.ehr.r4 | R4 | ValueSet-PatientContactRelationship | Patient Contact Relationship EHR | active | 2025-04 | ca | national | fhir tho | ||
fhir.cdc.opioid-cds-r4 | R4 | hospice-disposition | Hospice Disposition | active | 2023-05 | us | hl7 | |||
hl7.fhir.us.core | R4 | us-core-specimen-condition | US Core Specimen Condition | trial-use | 2 | cgp | 2024-11 | us | hl7 | vsac tho |
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-event-type | RTPBC Event Type Value Set | trial-use | 4 | phx | 2020-05 | us | hl7 | fhir |
hl7.fhir.us.specialty-rx | R4 | specialty-rx-event-type | Specialty Rx Value Set - Event Type | active | 2020-05 | us | hl7 | fhir | ||
hl7.fhir.us.mdi | R4 | vs-cremation-clearance-status | Cremation Clearance Status | trial-use | 3 | pher | 2025-07 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-certified-workflow | Certified Workflow | trial-use | 3 | pher | 2025-07 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-registration | Registration | trial-use | 3 | pher | 2025-07 | us | hl7 | fhir |
hl7.fhir.uv.pharm-quality | R5 | vs-deviceType-pq | Device Type | active | brr | 2024-05 | uv | hl7 | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-goalPriority-pq | Goal Priority | active | brr | 2024-05 | uv | hl7 | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-manufactured-item-property-pq | Manufactured Item Property | active | brr | 2024-05 | uv | hl7 | fhir | |
hl7.fhir.us.mdi | R4 | vs-med-dq-review | Medical Data Quality Review | trial-use | 3 | pher | 2025-07 | us | hl7 | fhir |
hl7.fhir.uv.pharm-quality | R5 | vs-qualifiedValueCriticality-pq | Qualified Value Criticality | active | brr | 2024-05 | uv | hl7 | tho | |
hl7.fhir.us.mdi | R4 | vs-per-dq-review | Personal Data Quality Review | trial-use | 3 | pher | 2025-07 | us | hl7 | fhir |
hl7.fhir.uv.pharm-quality | R5 | vs-productNameType-pq | Product Name Type | active | brr | 2024-05 | uv | hl7 | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-specification-type-pq | Specification Type | active | brr | 2024-05 | uv | hl7 | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-substance-property-pq | Substance Property | active | brr | 2024-05 | uv | hl7 | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-substance-property-value-pq | Substance Property Value | active | brr | 2024-05 | uv | hl7 | fhir | |
hl7.fhir.uv.pharm-quality | R5 | vs-test-method-pq | Test Method | active | brr | 2024-05 | uv | hl7 | fhir | |
hl7.fhir.us.mdi | R4 | vs-dcr-reason | Death Certificate Review Reason | trial-use | 3 | pher | 2025-07 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-signature-status | Signature Status | trial-use | 3 | pher | 2025-07 | us | hl7 | fhir |
hl7.fhir.us.mdi | R4 | vs-me-cert-affirmation | Medical Examiner Certification Status | trial-use | 3 | pher | 2025-07 | us | hl7 | fhir |
ca.on.mi.pkg | R4 | local-mi-procedure-types | Local Procedure Types | active | 2025-05 | ca | oid | |||
hl7.fhir.uv.pharm-quality | R5 | vs-process-validation-procedure-pq | Process Validation Procedure | active | brr | 2024-05 | uv | hl7 | fhir | |
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-pharmacy-type | RTPBC Pharmacy Type Value Set | trial-use | 4 | phx | 2020-05 | us | hl7 | tho |
ehelse.fhir.no.grunndata.test | R4 | gd-provenance-activity-type | Gd-Provenance activity type. Provenance actitivity types from Persontjenesten. | draft | 2020-04 | tho | ||||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1123 | COVID_19 (Disorders) (ICD10CM) | active | 2023-01 | us | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1124 | COVID_19 (Disorders) (SNOMED) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1142 | COVID_19 (Tests for SARS_CoV_2 Nucleic Acid) | active | 2025-02 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1143 | COVID_19 (Organism or Substance in Lab Results) | active | 2025-02 | us | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1158 | COVID_19 (Tests for SARS_CoV_2 Antigen) | active | 2024-01 | us | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.1409 | COVID_19 (Tests for SARS_CoV_2 Genomic Sequence) | active | 2025-02 | us | hl7 | loinc | ||
hl7.fhir.us.specialty-rx | R4 | specialty-rx-task-input-type | Specialty Rx Value Set - Task Input Type | active | 2023-01 | us | hl7 | fhir | ||
hl7.fhir.us.specialty-rx | R4 | specialty-rx-task-output-type | Specialty Rx Value Set - Task Output Type | active | 2023-01 | us | hl7 | fhir | ||
hl7.fhir.us.specialty-rx | R4 | specialty-rx-task-type | Specialty Rx Value Set - Task Type | active | 2023-01 | us | hl7 | fhir | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7933 | Cause of Fetal Death ICD-10 | active | 2020-01 | us | icd | |||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-error-code | RTPBC Error Code Value Set | trial-use | 4 | phx | 2020-05 | us | hl7 | tho |
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-billing-unit | RTPBC Billing Unit Value Set | trial-use | 4 | phx | 2020-05 | us | hl7 | ucum |
hl7.fhir.fi.base | R4 | fi-base-register-identifier | Finnish ValueSet for systems of registry specifiers | draft | 2025-08 | fi | hl7 | ietf | ||
hl7.fhir.us.carin-rtpbc | R4 | rtpbc-state-and-province-code | RTPBC Two Letter State and Province Code Value Set | trial-use | 4 | phx | 2020-05 | us | hl7 | |
ndhm.in | R4 | ndhm-tobacco-chewing-status | Tobacco Chewing Status | draft | 2021-03 | in | national | sct |